These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 30794951

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.
    Lee KK, Maccallum DM, Jacobsen MD, Walker LA, Odds FC, Gow NA, Munro CA.
    Antimicrob Agents Chemother; 2012 Jan; 56(1):208-17. PubMed ID: 21986821
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.
    Lackner M, Tscherner M, Schaller M, Kuchler K, Mair C, Sartori B, Istel F, Arendrup MC, Lass-Flörl C.
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3626-35. PubMed ID: 24733467
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
    Park S, Kelly R, Kahn JN, Robles J, Hsu MJ, Register E, Li W, Vyas V, Fan H, Abruzzo G, Flattery A, Gill C, Chrebet G, Parent SA, Kurtz M, Teppler H, Douglas CM, Perlin DS.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
    [Abstract] [Full Text] [Related]

  • 10. Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates.
    Walraven CJ, Bernardo SM, Wiederhold NP, Lee SA.
    Med Mycol; 2014 Feb; 52(2):131-139. PubMed ID: 24576999
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
    Desnos-Ollivier M, Bretagne S, Raoux D, Hoinard D, Dromer F, Dannaoui E, European Committee on Antibiotic Susceptibility Testing.
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282
    [Abstract] [Full Text] [Related]

  • 13. Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans.
    Angiolella L, Stringaro AR, De Bernardis F, Posteraro B, Bonito M, Toccacieli L, Torosantucci A, Colone M, Sanguinetti M, Cassone A, Palamara AT.
    Antimicrob Agents Chemother; 2008 Mar; 52(3):927-36. PubMed ID: 18180350
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Susceptibility of Candida albicans to common and novel antifungal drugs, and relationship between the mating type locus and resistance, in Lebanese hospital isolates.
    Basma R, Barada G, Ojaimi N, Khalaf RA.
    Mycoses; 2009 Mar; 52(2):141-8. PubMed ID: 18627469
    [Abstract] [Full Text] [Related]

  • 18. Evolutionary dynamics in gut-colonizing Candida glabrata during caspofungin therapy: Emergence of clinically important mutations in sphingolipid biosynthesis.
    Hassoun Y, Aptekmann AA, Keniya MV, Gomez RY, Alayo N, Novi G, Quinteros C, Kaya F, Zimmerman M, Caceres DH, Chow NA, Perlin DS, Shor E.
    PLoS Pathog; 2024 Sep; 20(9):e1012521. PubMed ID: 39250486
    [Abstract] [Full Text] [Related]

  • 19. Relationship between Sap prevalence and biofilm formation among resistant clinical isolates of Candida albicans.
    Kadry AA, El-Ganiny AM, El-Baz AM.
    Afr Health Sci; 2018 Dec; 18(4):1166-1174. PubMed ID: 30766582
    [Abstract] [Full Text] [Related]

  • 20. Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.
    Perrine-Walker F.
    Braz J Microbiol; 2022 Sep; 53(3):1101-1113. PubMed ID: 35352319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.